• Search
  • Helpdesk
  • Sales contact

Kayentis Partners with OmniComm to Offer Integrated EDC and eCOA Solutions

7 June 2018

OmniComm New Logo_Aug2010






Fort Lauderdale, FL – OmniComm Systems, Inc. (OTCQX: OMCM), a leading global provider of clinical data management technology, today announced a partnership with Kayentis, a global provider of electronic Clinical Outcome Assessment (eCOA) solutions for patient data collection in clinical trials. Under the terms of the partnership, the two companies will work together to provide life science clients with OmniComm’s TrialMaster® electronic data capture (EDC) suite integrated with Clin’form®, eCOA solution Suite from Kayentis — thereby offering an enhanced integration of the two platforms.

Prior to the partnership, a number of clients had independently selected both OmniComm and Kayentis for best-in-class data capture solutions. Therefore, the strategic relationship represents a logical fit and brings an exciting opportunity to streamline EDC and eCOA data capture, according to executives from both companies.

“After successfully implementing projects alongside OmniComm, we are thrilled to grow our partnership and bring it to this new step. Both companies share strong values and strive to provide customers, clinical sites and patients with the most efficient, easy-to-use and comprehensive solutions,” said Guillaume Juge, CEO at Kayentis.

Smart phones, tablets and other devices serve an expanding role in clinical trials as doctors, nurses and other researchers increasingly use mobile devices to collect trial data. Likewise, patients using mobile devices and wearable technology have heightened the need for electronic patient-reported outcome (ePRO) solutions.

Through joint marketing and business development initiatives, the two companies will work together to deliver OmniComm’s EDC technology and services integrated with eCOA solutions from Kayentis.

“OmniComm is delighted to be forging a formal relationship with Kayentis that will benefit our clients who need eCOA technology,” said Stephen Johnson, president & CEO of OmniComm Systems. “More and more, we see the voice of the patient/subject becoming critical to the success of studies, and we feel that Kayentis’ technology and support will bring enormous value.”

Download the press release


About Kayentis
Kayentis is a global provider of electronic Clinical Outcome Assessment (eCOA) solutions for patient data collection in clinical trials. Created in 2003, Kayentis has specialized in eCOA solutions since 2009, developing a full range of services and extending its solutions portfolio to support pharmaceutical companies, biotechnology companies and CROs. Today, with experience of more than 150 clinical trials in 75+ countries (6,500 sites and 50,000 patients) and in a broad range of therapeutic areas, Kayentis adds value to data quality and clinical trial efficiency with innovative and intuitive solutions. Please visit kayentis.com for more information.

About OmniComm Systems, Inc.
OmniComm Systems, Inc. is a leading strategic software solutions provider to the life sciences industry. OmniComm is dedicated to helping the world’s pharmaceutical, biotechnology, contract research organizations, diagnostic and device firms, and academic medical centers maximize the value of their clinical research investments. Through the use of innovative and progressive technologies, research organizations drive efficiency in clinical development, better manage risks, ensure regulatory compliance and manage their clinical operations performance. OmniComm provides comprehensive solutions for clinical research with an extensive global experience from more than 6,000 clinical trials. Please visit www.omnicomm.com for more information.

OmniComm, TrialMaster and TrialOne are registered trademarks of OmniComm Systems, Inc. Clin’form is a registered trademark of Kayentis.

Contact Info
Kuno van der Post
OmniComm Systems, Inc.

Guillaume Juge

Follow us on social media
Subscribe to our newsletter
About the author
Meet us at the following events

Mobile in Clinical Trials

16 SEPT 2024 • Philadelphia, USA

DPharm 2024

17-18 SEPT 2024 • Philadelphia, USA

SCDM 2024

29 SEPT - 2 OCT 2024 • Boston, USA


13-16 OCT 2024 • Cologne, Germany


10-13 NOV 2024 • Cologne, Germany

DMB 2024

13 NOV 2024 • Paris, France

SCOPE 2025

FEB 3-6 2025 • Orlando, USA
Booth #931 https://www.scopesummit.com/